Teresa Magnes (T Magnes)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Locally Advanced

Ejection Fraction

Prognostic Factors

Squamous Cell Carcinoma

Top Venues

International journal of molecular sciences

The pharmacogenomics journal

This page only lists publications with an associated author ORCID identifier.

Publications

Dominik Kiem, Sandro Wagner, Teresa Magnes, Alexander Egle, Richard Greil, Thomas Melchardt
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms. International journal of molecular sciences 22 (17) (2021)
Teresa Magnes, Sandro Wagner, Dominik Kiem, Lukas Weiss, Gabriel Rinnerthaler, Richard Greil, Thomas Melchardt
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 22 (9) (2021)
Teresa Magnes, Sandro Wagner, Aaron R Thorner, Daniel Neureiter, Eckhard Klieser, Gabriel Rinnerthaler, Lukas Weiss, Florian Huemer, Konstantin Schlick, Nadja Zaborsky, Markus Steiner, Richard Greil, Alexander Egle, Thomas Melchardt
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies. Cancers 13 (4) (2021)
Teresa Magnes, T Melchardt, C Hufnagl, L Weiss, C Mittermair, D Neureiter, E Klieser, G Rinnerthaler, S Roesch, A Gaggl, R Greil, Alexander Egle
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab. The pharmacogenomics journal 18 (3) (2017)
Teresa Magnes, Alexander Egle, Richard Greil, Thomas Melchardt
Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017. Memo 10 (4) (2017)
Teresa Magnes, Thomas Melchardt, Lukas Weiss, Christof Mittermair, Daniel Neureiter, Eckhard Klieser, Simon Gampenrieder, Gerhard Moser, Alexander Gaggl, Richard Greil, Alexander Egle
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy. PloS one 12 (7) (2017)